Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Receivables (2016 - 2025)

Historic Receivables for Alkermes (ALKS) over the last 15 years, with Q3 2025 value amounting to $355.1 million.

  • Alkermes' Receivables fell 407.07% to $355.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $355.1 million, marking a year-over-year decrease of 407.07%. This contributed to the annual value of $389.5 million for FY2024, which is 1690.81% up from last year.
  • As of Q3 2025, Alkermes' Receivables stood at $355.1 million, which was down 407.07% from $356.3 million recorded in Q2 2025.
  • Over the past 5 years, Alkermes' Receivables peaked at $389.5 million during Q4 2024, and registered a low of $250.0 million during Q1 2022.
  • Moreover, its 5-year median value for Receivables was $321.8 million (2025), whereas its average is $317.6 million.
  • As far as peak fluctuations go, Alkermes' Receivables crashed by 1569.15% in 2022, and later surged by 2750.47% in 2023.
  • Over the past 5 years, Alkermes' Receivables (Quarter) stood at $326.6 million in 2021, then decreased by 9.08% to $296.9 million in 2022, then increased by 12.22% to $333.2 million in 2023, then increased by 16.91% to $389.5 million in 2024, then decreased by 8.83% to $355.1 million in 2025.
  • Its Receivables stands at $355.1 million for Q3 2025, versus $356.3 million for Q2 2025 and $321.8 million for Q1 2025.